| A pilot study of a system for grading of drainage blebs after glaucoma surgery AP Wells, JG Crowston, J Marks, JF Kirwan, G Smith, JCK Clarke, R Shah, ... Journal of glaucoma 13 (6), 454-460, 2004 | 242 | 2004 |
| Decoding melanoma development and progression: identification of therapeutic vulnerabilities K Eddy, R Shah, S Chen Frontiers in oncology 10, 626129, 2021 | 98 | 2021 |
| Pain relief after abdominal surgery—a comparison of im morphine, sublingual buprenorphine and self-administered iv pethidine R Ellis, D Haines, R Shah, BR Cotton, G Smith BJA: British Journal of Anaesthesia 54 (4), 421-428, 1982 | 98 | 1982 |
| Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3 … DK Burns, RC Alexander, KA Welsh-Bohmer, M Culp, C Chiang, J O’Neil, ... The Lancet Neurology 20 (7), 537-547, 2021 | 85 | 2021 |
| Concurrent targeting of glutaminolysis and metabotropic glutamate receptor 1 (GRM1) reduces glutamate bioavailability in GRM1+ melanoma R Shah, SJ Singh, K Eddy, FV Filipp, S Chen Cancer research 79 (8), 1799-1809, 2019 | 46 | 2019 |
| Metabotropic glutamate receptor 1 disrupts mammary acinar architecture and initiates malignant transformation of mammary epithelial cells JLF Teh, R Shah, S La Cava, SC Dolfi, MS Mehta, S Kongara, S Price, ... Breast cancer research and treatment 151, 57-73, 2015 | 34 | 2015 |
| Metabolic signaling cascades prompted by glutaminolysis in cancer R Shah, S Chen Cancers 12 (9), 2624, 2020 | 32 | 2020 |
| Linker variation and structure–activity relationship analyses of carboxylic acid-based small molecule stat3 inhibitors F Lopez-Tapia, C Brotherton-Pleiss, P Yue, H Murakami, AC Costa Araujo, ... ACS medicinal chemistry letters 9 (3), 250-255, 2018 | 25 | 2018 |
| Dipeptide prodrugs of the glutamate modulator riluzole JC Pelletier, S Chen, H Bian, R Shah, GR Smith, JE Wrobel, AB Reitz ACS medicinal chemistry letters 9 (7), 752-756, 2018 | 21 | 2018 |
| Metabotropic glutamate receptor 1 mediates melanocyte transformation via transactivation of insulin‐like growth factor 1 receptor JLF Teh, R Shah, SS Shin, Y Wen, JM Mehnert, J Goydos, S Chen Pigment cell & melanoma research 27 (4), 621-629, 2014 | 18 | 2014 |
| Implications of a neuronal receptor family, metabotropic glutamate receptors, in cancer development and progression K Eddy, MN Eddin, A Fateeva, SVB Pompili, R Shah, S Doshi, S Chen Cells 11 (18), 2857, 2022 | 16 | 2022 |
| Recent perspectives on APP, secretases, endosomal pathways and how they influence Alzheimer’s related pathological changes in Down syndrome B DeCourt, W Mobley, E Reiman, RJ Shah, MN Sabbagh Journal of Alzheimer's disease & Parkinsonism, 002, 2013 | 13 | 2013 |
| A spontaneous melanoma mouse model applicable for a longitudinal chemotherapy and immunotherapy study K Eddy, K Gupta, JC Pelletier, AL Isola, C Marinaro, MA Rasheed, ... Journal of Investigative Dermatology 143 (10), 2007-2018. e6, 2023 | 5 | 2023 |
| Evolution of biodiesel testing standards and specifications globally R Shah, S Porter Biofuels 5 (1), 17-19, 2014 | 3 | 2014 |
| GRM1 to induce M-CSF and CCL2 expression to lead to an upregulation of M2 macrophages in melanoma. J Li, Y Wen, BS Jeong, R Shah, A Isola, AW Silk, S Chen, JS Goydos Journal of Clinical Oncology 35 (7_suppl), 122-122, 2017 | 2 | 2017 |
| 778 Preclinical study using a glutamatergic signaling and immune-checkpoint inhibitors in a spontaneous melanoma prone mouse model K Eddy, C Marinaro, M Rasheed, J Campagnolo, X Zhong, M Eddin, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | | 2020 |
| Targeting glutamate metabolism in melanoma S Singh, R Shah, S Chen, FV Filipp arXiv preprint arXiv:1912.07668, 2019 | | 2019 |
| Concurrent inhibition of glutaminase (GLS) and metabotropic receptor 1 (GRM1) reduced glutamate bioavailability and led to a decrease in GRM1-expressing melanoma cell … R Shah, S Singh, K Eddy, F Filipp, S Chen Cancer Research 79 (13_Supplement), 1839-1839, 2019 | | 2019 |
| Targeted inhibition of glutaminase in GRM1-expressing melanoma cells inhibits cell proliferation by reducing glutamate bioavailability R Shah, M Zhu, A Boreland, F Filipp, S Chen Cancer Research 78 (13_Supplement), 5493-5493, 2018 | | 2018 |
| The relationship between glutamatergic signaling and altered glutamine metabolism in melanoma R Shah, A Boreland, S Chen Cancer Research 77 (13_Supplement), 5419-5419, 2017 | | 2017 |
